{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:22:45Z","timestamp":1786764165323,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.eplepsyres.2006.05.003","type":"journal-article","created":{"date-parts":[[2006,6,11]],"date-time":"2006-06-11T09:58:40Z","timestamp":1150019920000},"page":"190-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings"],"prefix":"10.1016","volume":"70","author":[{"given":"B\u00e9la","family":"Clemens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"M\u00e9nes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1lma","family":"Piros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nika","family":"Bessenyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Jerney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Koll\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Rosdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"R\u00f3zsav\u00f6lgyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Steinecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Holl\u00f3dy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.eplepsyres.2006.05.003_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1528-1157.2001.00516.x","article-title":"Effects of antiepileptic drugs on cognition","volume":"42","author":"Aldenkamp","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1528-1157.2002.29201.x","article-title":"Randomized double-blind parallel-group study comparing cognitive effects of a low dose lamotrigine with valproate","volume":"43","author":"Aldenkamp","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0387-7604(87)80049-9","article-title":"Predictive factors of seizure frequency and duration on antiepileptic treatment in rolandic epilepsy: a retrospective study","volume":"9","author":"Ambrosetto","year":"1987","journal-title":"Brain Dev."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.clinph.2003.11.034","article-title":"Peak alpha frequency: an electroencephalographic measure of cognitive preparedness","volume":"115","author":"Angelaikis","year":"2004","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib5","series-title":"Brain Function and Oscillations. Vol. II: Integrative Brain Function. Neurophysiology and Cognitive Processes","first-page":"393","article-title":"Brain functioning: integrative models","author":"Basar","year":"1999"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0013-4694(92)90128-5","article-title":"EEG changes in patients during the introduction of carbamazepine","volume":"83","author":"Besser","year":"1992","journal-title":"Electroenceph. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib7","first-page":"307","article-title":"Valproate treatment normalises EEG frequency profiles in idiopathic (primary) generalised epilepsy (In Hungarian English Abstract)","volume":"52","author":"Clemens","year":"1999","journal-title":"Clin. Neurosci.\/Ideggy Szle"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib8","first-page":"92","article-title":"Occipital spectral EEG-parameters in newly diagnosed, untreated epilepsy patients (In Hungarian English Abstract)","volume":"56","author":"Clemens","year":"2003","journal-title":"Clin. Neurosci.\/Ideggy Szle"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1600-0404.2003.00234.x","article-title":"Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine","volume":"109","author":"Clemens","year":"2004","journal-title":"Acta Neurol. Scand."},{"issue":"suppl. 1","key":"10.1016\/j.eplepsyres.2006.05.003_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1528-1157.2001.042004575.x","article-title":"Learning disability in epilepsy: definitions and classification","volume":"42","author":"Cornaggia","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib11","first-page":"57","article-title":"Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance","volume":"12","author":"Frost","year":"1995","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0013-4694(85)90005-7","article-title":"Test\u2013retest reliability of spectral parameters of the EEG","volume":"60","author":"Gasser","year":"1985","journal-title":"Electroenceph. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Commission on classification and terminology: proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","author":"ILAE","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0301-0082(83)90014-X","article-title":"Neurometric evaluation of cognitive dysfunctions and neurological disorders in children","volume":"21","author":"John","year":"1983","journal-title":"Progr. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-0173(98)00056-3","article-title":"EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis","volume":"29","author":"Klimesch","year":"1999","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/155005949502600209","article-title":"Effects of antiepileptic drugs on EEG background activity in children with epilepsy","volume":"26","author":"Konishi","year":"1995","journal-title":"Clin. Electroenceph."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"42","author":"Kwan","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01870612","article-title":"Neither dosage nor serum levels of the antiepileptic drugs are predictive for efficacy and adverse effects","volume":"17","author":"Lammers","year":"1995","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib19","series-title":"Antiepileptic drugs","year":"1995"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.10463","article-title":"Progressive neocortical damage in epilepsy","volume":"53","author":"Liu","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib21","series-title":"Quantitative Assessment in Epilepsy Care","first-page":"123","article-title":"Quantitative assessment of adverse drug effects","author":"Mattson","year":"1993"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1528-1157.1993.tb02389.x","article-title":"Effects of carbamazepine and phenytoin on EEG and memory in healthy adults","volume":"34","author":"Meador","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1528-1157.1986.tb03550.x","article-title":"Behavioral toxicity associated with antiepileptic drug: concepts and methods of assessment","volume":"27","author":"Novelly","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hbm.1030","article-title":"Spatio-temporal structures of human alpha rhythms: theory, microcurrent sources, multiscale measurements, and global binding of local networks","volume":"13","author":"Nunez","year":"2001","journal-title":"Hum. Brain Mapping"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004691-198801000-00001","article-title":"Quantitative EEG. 1. Techniques and problems of frequency analysis and topographic mapping","volume":"5","author":"Nuwer","year":"1988","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004691-198801000-00002","article-title":"Quantitative EEG: 2. Frequency analysis and topographic mapping in clinical settings","volume":"5","author":"Nuwer","year":"1988","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0013-4694(94)90011-6","article-title":"IFCN guidelines for topographic and frequency analysis of EEGs and EPs. Report of an IFCN committee","volume":"91","author":"Nuwer","year":"1994","journal-title":"Electroenceph. Clin. Neurophysiol."},{"issue":"Suppl. 3","key":"10.1016\/j.eplepsyres.2006.05.003_bib28","first-page":"S64","article-title":"Carbamazepine side effects in children and adults","volume":"28","author":"Pellock","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib29","first-page":"385","article-title":"Topographic brain mapping of EEG in neuropsychopharmacology. Part II. Clinical applications (Pharmaco EEG imaging)","volume":"9","author":"Saletu","year":"1987","journal-title":"Meth. Find. Exp. Clin. Pharmacol."},{"issue":"Suppl. C","key":"10.1016\/j.eplepsyres.2006.05.003_bib30","first-page":"97","article-title":"Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA)","volume":"24","author":"Saletu","year":"2002","journal-title":"Meth. Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib31","first-page":"362","article-title":"Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry","volume":"24","author":"Saletu","year":"1986","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1528-1157.2002.22501.x","article-title":"Effects of gabapentine and carbamazepine on the EEG and cognition in healthy volunteers","volume":"43","author":"Salinsky","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1046\/j.1528-1157.2003.60602.x","article-title":"Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures","volume":"44","author":"Salinsky","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib34","first-page":"231","article-title":"Quantitative EEG effects and plasma concentration of sodium valproate: acute and long-term administration to epileptic patients","volume":"22","author":"Sannita","year":"1989","journal-title":"Pharmacoelectroencephalography"},{"issue":"Suppl. 2","key":"10.1016\/j.eplepsyres.2006.05.003_bib35","first-page":"96","article-title":"Carbamazepine in patients with epilepsy: subjective complaints but no objective impairment of cognitive function","volume":"40","author":"Sommer","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib36","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.clinph.2005.04.026","article-title":"EEG and intelligence: relations between EEG coherence, EEG phase delay and power","volume":"116","author":"Thatcher","year":"2005","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2006.05.003_bib37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1528-1157.1995.tb01620.x","article-title":"Spectral EEG during short-term discontinuation of antiepileptic medication in partial epilepsy","volume":"36","author":"Tuunainen","year":"1995","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121106001446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121106001446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:16:21Z","timestamp":1760274981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121106001446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":37,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0920121106001446"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2006.05.003","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2006.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}